Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Clinical trial NCT06258629 · UNKNOWN
Trial details
- NCT number
- NCT06258629
- Sponsor
- Sohag University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-15
- Primary completion
- 2025-02-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.